Formation of lipid raft redox signalling platforms in glomerular endothelial cells: An early event of homocysteine-induced glomerular injury

Journal of Cellular and Molecular Medicine

Volumn 13, Issue 9 B, 2009, Pages 3303-3314

  Yi, Fan ^a   Jin, Si ^a   Zhang, Fan ^a   Xia, Min ^a   Bao, Jun Xiang ^a   Hu, Junjun ^a   Poklis, Justin L ^a   Li, Pin Lan ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Glomerular sclerosis; Hyperfiltration; Hyperhomocysteinemia; Lipid microdomains

Indexed keywords

CYBB PROTEIN, RAT; HOMOCYSTEINE; LIPID; MEMBRANE PROTEIN; NEUTROPHIL CYTOSOLIC FACTOR 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ANIMAL; ARTICLE; CELL MEMBRANE; CHEMISTRY; CONFOCAL MICROSCOPY; CYTOLOGY; ENDOTHELIUM CELL; GLOMERULUS; KIDNEY; MALE; METABOLISM; METHODOLOGY; MICROTUBULE; OXIDATION REDUCTION REACTION; PATHOLOGY; PERMEABILITY; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; ENDOTHELIAL CELLS; HOMOCYSTEINE; KIDNEY; KIDNEY GLOMERULUS; LIPIDS; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE MICRODOMAINS; MICROSCOPY, CONFOCAL; MICROTUBULES; NADPH OXIDASE; OXIDATION-REDUCTION; PERMEABILITY; RATS; RATS, SPRAGUE-DAWLEY;

EID: 77449118614     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2009.00743.x     Document Type: Article

References (38)

1. Bostom AG, Lathrop L. Hyperhomocysteinemia in end-stage renal disease: prevalence, etiology, and potential relationship to arteriosclerotic outcomes. Kidney Int. 1997, 52:10-20.
2. Mills JL, Scott JM, Kirke PN. Homocysteine and neural tube defects. J Nutr. 1996, 126:756S-60S.
3. Perna AF, Ingrosso D, Satta E. Homocysteine metabolism in renal failure. Curr Opin Clin Nutr Metab Care. 2004, 7:53-7.
4. Suliman ME, Stenvinkel P, Barany P. Hyperhomocysteinemia, malnutrition, and inflammation in ESRD patients. Semin Nephrol. 2006, 26:14-9.
5. Yi F, Li PL. Mechanisms of homocysteine-induced glomerular injury and sclerosis. Am J Nephrol. 2008, 28:254-64.
6. Li N, Chen YF, Zou AP. Implications of hyperhomocysteinemia in glomerular sclerosis in hypertension. Hypertension. 2002, 39:443-8.
7. Yi F, Zhang AY, Janscha JL. Homocysteine activates NADH/NADPH oxidase through ceramide-stimulated Rac GTPase activity in rat mesangial cells. Kidney Int. 2004, 66:1977-87.
8. Yi F, Zhang AY, Li N. Inhibition of ceramide-redox signaling pathway blocks glomerular injury in hyperhomocysteinemic rats. Kidney Int. 2006, 70:88-96.
9. Shastry S, Ingram AJ, Scholey JW. Homocysteine induces mesangial cell apoptosis via activation of p38-mitogen-activated protein kinase. Kidney Int. 2007, 71:304-11.
10. Yamanaka N, Shimizu A. Role of glomerular endothelial damage in progressive renal disease. Kidney Blood Press Res. 1999, 22:13-20.
11. Shankland SJ. The podocyte's response to injury: role in proteinuria and glomerulosclerosis. Kidney Int. 2006, 69:2131-47.
12. Yi F, Dos Santos EA, Xia M. Podocyte Injury and Glomerulosclerosis in Hyperhomocysteinemic Rats. Am J Nephrol. 2007, 27:262-8.
13. Maynard SE, Min JY, Merchan J. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest. 2003, 111:649-58.
14. Singh A, Satchell SC, Neal CR. Glomerular endothelial glycocalyx constitutes a barrier to protein permeability. J Am Soc Nephrol. 2007, 18:2885-93.
15. Bollinger CR, Teichgraber V, Gulbins E. Ceramide-enriched membrane domains. Biochim Biophys Acta. 2005, 1746:284-94.
16. Gulbins E, Dreschers S, Wilker B. Ceramide, membrane rafts and infections. J Mol Med. 2004, 82:357-63.
17. Gulbins E, Li PL. Physiological and pathophysiological aspects of ceramide. Am J Physiol Regul Integr Comp Physiol. 2006, 290:R11-26.
18. Tanaka T, Miyata T, Inagi R. Hypoxia-induced apoptosis in cultured glomerular endothelial cells: involvement of mitochondrial pathways. Kidney Int. 2003, 64:2020-32.
19. Adler S, Eng B. Integrin receptors and function on cultured glomerular endothelial cells. Kidney Int. 1993, 44:278-84.
20. Fillet M, Van Heugen JC, Servais AC. Separation, identification and quantitation of ceramides in human cancer cells by liquid chromatography-electrospray ionization tandem mass spectrometry. J Chromatogr A. 2002, 949:225-33.
21. Zhang AY, Yi F, Jin S. Acid sphingomyelinase and its redox amplification in formation of lipid raft redox signaling platforms in endothelial cells. Antioxid Redox Signal. 2007, 9:817-28.
22. Jin S, Zhang Y, Yi F. Critical role of lipid raft redox signaling platforms in endostatin-induced coronary endothelial dysfunction. Arterioscler Thromb Vasc Biol. 2007, 28:485-90.
23. Zhang AY, Yi F, Zhang G. Lipid raft clustering and redox signaling platform formation in coronary arterial endothelial cells. Hypertension. 2006, 47:74-80.
24. Zhang DX, Zou AP, Li PL. Ceramide-induced activation of NADPH oxidase and endothelial dysfunction in small coronary arteries. Am J Physiol Heart Circ Physiol. 2003, 284:H605-12.
25. Siow YL, Au-Yeung KK, Woo CW. Homocysteine stimulates phosphorylation of NADPH oxidase p47phox and p67phox subunits in monocytes via protein kinase Cbeta activation. Biochem J. 2006, 398:73-82.
26. Zhang F, Jin S, Yi F. Local production of O(2)(-) by NAD(P)H oxidase in the sarcoplasmic reticulum of coronary arterial myocytes: cADPR-mediated Ca(2+) regulation. Cell Signal. 2007, 20:637-44.
27. Ying CJ, Xu JW, Ikeda K. Tea polyphenols regulate nicotinamide adenine dinucleotide phosphate oxidase subunit expression and ameliorate angiotensin II-induced hyperpermeability in endothelial cells. Hypertens Res. 2003, 26:823-8.
28. Hordijk PL, Anthony E, Mul FP. Vascular-endothelial-cadherin modulates endothelial monolayer permeability. J Cell Sci. 1999, 112:1915-23.
29. Birukova AA, Birukov KG, Adyshev D. Involvement of microtubules and Rho pathway in TGF-beta1-induced lung vascular barrier dysfunction. J Cell Physiol. 2005, 204:934-47.
30. McCully KS. Hyperhomocysteinemia and arteriosclerosis: historical perspectives. Clin Chem Lab Med. 2005, 43:980-6.
31. Refsum H, Ueland PM, Nygard O. Homocysteine and cardiovascular disease. Annu Rev Med. 1998, 49:31-62.
32. Li PL, Zhang Y, Yi F. Lipid raft redox signaling platforms in endothelial dysfunction. Antioxid Redox Signal. 2007, 9:1457-70.
33. Lum H, Roebuck KA. Oxidant stress and endothelial cell dysfunction. Am J Physiol Cell Physiol. 2001, 280:C719-41.
34. Simionescu M. Implications of early structural-functional changes in the endothelium for vascular disease. Arterioscler Thromb Vasc Biol. 2007, 27:266-74.
35. Seeger W, Hansen T, Rossig R. Hydrogen peroxide-induced increase in lung endothelial and epithelial permeability-effect of adenylate cyclase stimulation and phosphodiesterase inhibition. Microvasc Res. 1995, 50:1-17.
36. Barnard ML, Matalon S. Mechanisms of extracellular reactive oxygen species injury to the pulmonary microvasculature. J Appl Physiol. 1992, 72:1724-9.
37. Tzima E. Role of small GTPases in endothelial cytoskeletal dynamics and the shear stress response. Circ Res. 2006, 98:176-85.
38. Bernhard D, Csordas A, Henderson B. Cigarette smoke metal-catalyzed protein oxidation leads to vascular endothelial cell contraction by depolymerization of microtubules. FASEB J. 2005, 19:1096-107.